ICON plc is a global leader in clinical research (CRO) and healthcare intelligence, providing outsourced development and commercialization services for pharmaceutical, biotech, medical device, and government organizations, helping them bring new drugs and treatments to market faster through expertise in areas like AI, data, and global trial management. Founded in Ireland in 1990, they manage complex clinical trials, from early development (Phase I) through commercialization, focusing on efficiency, quality, and patient access.